Ignite Creation Date:
2024-07-17 @ 11:43 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06493578
Status:
RECRUITING
Last Update Posted:
2024-07-10
First Post:
2024-03-18
Brief Title:
A Study to Evaluate the Efficacy Safety and Pharmacokinetics of VYN201 Gel in Subjects with Non-segmental Vitiligo
Sponsor:
Vyne Therapeutics Inc
Organization:
Vyne Therapeutics Inc
Study Overview
Official Title:
A Randomized Double-Blind Vehicle-Controlled Phase 2b Trial Evaluating the Efficacy Safety Pharmacokinetics of VYN201 Gel in the Treatment of Non Segmental Vitiligo
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the efficacy safety and pharmacokinetics of VYN201 Gel in subjects with non-segmental vitiligo
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None